The device is a single-patient-use stapler featuring 120 degrees of fully-wristed articulation, which Intuitive touts as “an industry first.”
Beyond the 60 mm device, Intuitive’s stapling portfolio includes 30 and 45 mm stapler instruments.
The stapler uses Intuitive’s SmartFire software to measure tissue compression before and during staple firing, automatically adjusting to the firing process as staples are formed, the company explained.
Surgeons control Intuitive’s latest stapler via the daVinci console – it’s compatible with the da Vinci Xi and X systems. The SureForm 60 device has general, thoracic, gynecologic, urologic and pediatric indications, according to Intuitive.
“Intuitive continues our minimally invasive innovation with our 60mm stapler, rooted in extensive research and development and an understanding of surgeons’ needs,” Sal Brogna, EVP & COO, said in prepared remarks.
ISRG shares were trading at $487.39 apiece in late afternoon activity today, up +0.4%.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.